179 related articles for article (PubMed ID: 12758240)
1. In vivo colocalization of 2-nitroimidazole EF5 fluorescence intensity and electron paramagnetic resonance oximetry in mouse tumors.
Mahy P; De Bast M; Gallez B; Gueulette J; Koch CJ; Scalliet P; Grégoire V
Radiother Oncol; 2003 Apr; 67(1):53-61. PubMed ID: 12758240
[TBL] [Abstract][Full Text] [Related]
2. Hypoxia in human intraperitoneal and extremity sarcomas.
Evans SM; Hahn SM; Magarelli DP; Zhang PJ; Jenkins WT; Fraker DL; Hsi RA; McKenna WG; Koch CJ
Int J Radiat Oncol Biol Phys; 2001 Feb; 49(2):587-96. PubMed ID: 11173159
[TBL] [Abstract][Full Text] [Related]
3. Effect of RSR13, an allosteric hemoglobin modifier, on oxygenation in murine tumors: an in vivo electron paramagnetic resonance oximetry and bold MRI study.
Hou H; Khan N; O'Hara JA; Grinberg OY; Dunn JF; Abajian MA; Wilmot CM; Makki M; Demidenko E; Lu S; Steffen RP; Swartz HM
Int J Radiat Oncol Biol Phys; 2004 Jul; 59(3):834-43. PubMed ID: 15183487
[TBL] [Abstract][Full Text] [Related]
4. Detection of tumour hypoxia: comparison between EF5 adducts and [18F]EF3 uptake on an individual mouse tumour basis.
Mahy P; De Bast M; Gillart J; Labar D; Grégoire V
Eur J Nucl Med Mol Imaging; 2006 May; 33(5):553-6. PubMed ID: 16523307
[TBL] [Abstract][Full Text] [Related]
5. Direct relationship between radiobiological hypoxia in tumors and monoclonal antibody detection of EF5 cellular adducts.
Lee J; Siemann DW; Koch CJ; Lord EM
Int J Cancer; 1996 Jul; 67(3):372-8. PubMed ID: 8707411
[TBL] [Abstract][Full Text] [Related]
6. Identification of hypoxia in cells and tissues of epigastric 9L rat glioma using EF5 [2-(2-nitro-1H-imidazol-1-yl)-N-(2,2,3,3,3-pentafluoropropyl) acetamide].
Evans SM; Joiner B; Jenkins WT; Laughlin KM; Lord EM; Koch CJ
Br J Cancer; 1995 Oct; 72(4):875-82. PubMed ID: 7547234
[TBL] [Abstract][Full Text] [Related]
7. Hypoxia and necrosis in rat 9L glioma and Morris 7777 hepatoma tumors: comparative measurements using EF5 binding and the Eppendorf needle electrode.
Jenkins WT; Evans SM; Koch CJ
Int J Radiat Oncol Biol Phys; 2000 Mar; 46(4):1005-17. PubMed ID: 10705024
[TBL] [Abstract][Full Text] [Related]
8. Immunocytochemical labelling of aerobic and hypoxic mammalian cells using a platinated derivative of EF5.
Matthews J; Adomat H; Farrell N; King P; Koch C; Lord E; Palcic B; Poulin N; Sangulin J; Skov K
Br J Cancer Suppl; 1996 Jul; 27():S200-3. PubMed ID: 8763880
[TBL] [Abstract][Full Text] [Related]
9. Detection of individual hypoxic cells in multicellular spheroids by flow cytometry using the 2-nitroimidazole, EF5, and monoclonal antibodies.
Woods ML; Koch CJ; Lord EM
Int J Radiat Oncol Biol Phys; 1996 Jan; 34(1):93-101. PubMed ID: 12118570
[TBL] [Abstract][Full Text] [Related]
10. Oxygen dependence of cellular uptake of EF5 [2-(2-nitro-1H-imidazol-1-yl)-N-(2,2,3,3,3-pentafluoropropyl)a cet amide] : analysis of drug adducts by fluorescent antibodies vs bound radioactivity.
Koch CJ; Evans SM; Lord EM
Br J Cancer; 1995 Oct; 72(4):869-74. PubMed ID: 7547233
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the Hypoxia PET Tracer (18)F-EF5 to Immunohistochemical Marker EF5 in 3 Different Human Tumor Xenograft Models.
Chitneni SK; Bida GT; Zalutsky MR; Dewhirst MW
J Nucl Med; 2014 Jul; 55(7):1192-7. PubMed ID: 24854792
[TBL] [Abstract][Full Text] [Related]
12. Detection of hypoxic cells with the 2-nitroimidazole, EF5, correlates with early redox changes in rat brain after perinatal hypoxia-ischemia.
Bergeron M; Evans SM; Sharp FR; Koch CJ; Lord EM; Ferriero DM
Neuroscience; 1999; 89(4):1357-66. PubMed ID: 10362320
[TBL] [Abstract][Full Text] [Related]
13. Biodistribution of the nitroimidazole EF5 (2-[2-nitro-1H-imidazol-1-yl]-N-(2,2,3,3,3-pentafluoropropyl) acetamide) in mice bearing subcutaneous EMT6 tumors.
Laughlin KM; Evans SM; Jenkins WT; Tracy M; Chan CY; Lord EM; Koch CJ
J Pharmacol Exp Ther; 1996 May; 277(2):1049-57. PubMed ID: 8627516
[TBL] [Abstract][Full Text] [Related]
14. A comparative evaluation of EPR and OxyLite oximetry using a random sampling of pO(2) in a murine tumor.
Vikram DS; Bratasz A; Ahmad R; Kuppusamy P
Radiat Res; 2007 Sep; 168(3):308-15. PubMed ID: 17705635
[TBL] [Abstract][Full Text] [Related]
15. Measurement of differences in pO2 in response to perfluorocarbon/carbogen in FSa and NFSa murine fibrosarcomas with low-frequency electron paramagnetic resonance oximetry.
Halpern HJ; Yu C; Peric M; Barth ED; Karczmar GS; River JN; Grdina DJ; Teicher BA
Radiat Res; 1996 May; 145(5):610-8. PubMed ID: 8619027
[TBL] [Abstract][Full Text] [Related]
16. Hypoxia-inducible factor-1alpha is an intrinsic marker for hypoxia in cervical cancer xenografts.
Vukovic V; Haugland HK; Nicklee T; Morrison AJ; Hedley DW
Cancer Res; 2001 Oct; 61(20):7394-8. PubMed ID: 11606368
[TBL] [Abstract][Full Text] [Related]
17. Comparative measurements of hypoxia in human brain tumors using needle electrodes and EF5 binding.
Evans SM; Judy KD; Dunphy I; Jenkins WT; Nelson PT; Collins R; Wileyto EP; Jenkins K; Hahn SM; Stevens CW; Judkins AR; Phillips P; Geoerger B; Koch CJ
Cancer Res; 2004 Mar; 64(5):1886-92. PubMed ID: 14996753
[TBL] [Abstract][Full Text] [Related]
18. 2-Nitroimidazole (EF5) binding predicts radiation resistance in individual 9L s.c. tumors.
Evans SM; Jenkins WT; Joiner B; Lord EM; Koch CJ
Cancer Res; 1996 Jan; 56(2):405-11. PubMed ID: 8542599
[TBL] [Abstract][Full Text] [Related]
19. In vivo measurement of the hypoxia marker EF5 in Shionogi tumours using (19)F magnetic resonance spectroscopy.
Hoff MN; Yapp DT; Yung AC; Oliver TS; Kozlowski P
Int J Radiat Biol; 2008 Mar; 84(3):237-42. PubMed ID: 18300024
[TBL] [Abstract][Full Text] [Related]
20. Electron Paramagnetic Resonance pO
Epel B; Maggio M; Pelizzari C; Halpern HJ
Adv Exp Med Biol; 2017; 977():287-296. PubMed ID: 28685458
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
